Sponsored By

Think Surgical Raises $100M for Orthopedic Surgical Robotic Products

Think Surgical will use the funds to bring new products to market that will work with implants from different manufacturers.

Susan Shepard

October 27, 2022

1 Min Read
IMG_2022-10-27-124357.jpg
Image courtesy of Anton Shaparenko / Alamy Stock Photo

KDB Investment Global Healthcare of Korea has invested $100 million in Think Surgical to enable the company to undertake a faster commercial launch of several new products that offer a common planning solution across multiple robotic platforms, along with a choice of implants from different manufacturers. 

Think Surgical offers robotic systems for joint replacement surgery that feature an open implant library, which gives customers a compelling alternative to closed systems that are limited to a single manufacturer's implants. The ability for surgeons to use implants from multiple implant manufacturers in combination with Think's robotic technology allows them to not only benefit from robotic-assisted surgery but also choose the implant that is best suited to each individual patient.

"We are extremely excited to strengthen our financial position to support successful new product commercialization through this financing round," said Stuart Simpson, president and CEO of Think Surgical, in prepared remarks. "KDB Investment is a highly sophisticated and respected professional investment firm, and their investment will help us expand our brand and presence in the industry.  "We greatly appreciate their confidence in Think Surgical as an investment opportunity."

KDB Investment believes that Think Surgical's differentiated business model will be embraced in the global market by customers looking for more flexibility and choice over current offerings.

"We are very impressed with the technology portfolio that Think Surgical has developed and is planning to commercialize.  We very much look forward to several planned product launches over the coming years," said DH Lee, CEO of KDB Investment, in a company statement.

 

 

 

About the Author(s)

Susan Shepard

Susan Shepard is a freelance contributor to MD + DI.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like